Beijing Boren Hospital

This early-stage study is testing a new treatment for people with a rare and aggressive type of brain lymphoma that has returned or not responded to standard therapies. The treatment uses the patient's own immune cells, which are modified in a lab to recognize and attack cancer c…

This early-stage study tests a new injection called AFN50 in 18 adults with autoimmune diseases that haven't responded to standard treatments. The goal is to see if AFN50 is safe and can help control the disease by targeting the immune system's B cells. Participants will be close…

This early study is testing a new treatment for people with autoimmune diseases like lupus, scleroderma, and multiple sclerosis that haven't gotten better with standard care. The treatment uses a patient's own immune cells, which are modified in a lab to target and calm the overa…